First new prescription treatment approved for smoking cessation in nearly a decade, received priority review designation by FDA. Addiction to nicotine is a chronic medical condition that makes quitting smoking difficult. Chantix is a breakthrough treatm
- the smoking cessation drug
Published on August 30, 2006 By know-chantix In Welcome
Chantix, which works on specific parts of the brain, helps people give up smoking in two ways:

-- It provides some satisfaction that nicotine gives, hence lessening withdrawal symptoms

-- It blocks the nicotine from entering relevant parts of the brain, thus eliminating the reward a smoker feels when he/she smokes

Addiction to nicotine is a habit that is very difficult for many smokers to quit. When smokers inhale smoke from a cigarette, nicotine reaches the brain within seconds and binds to nicotinic receptors, which activates the reward pathway in brain circuitry. This stimulates the pleasure center in the brain. The initial effects recede quickly and a cycle of craving and withdrawal takes hold.

Chantix is unique because it is specifically designed to partially activate the nicotinic receptor and reduce the severity of the smoker’s craving and the withdrawal symptoms from nicotine. Moreover, if a person smokes a cigarette while receiving treatment, Chantix has the potential to diminish the sense of satisfaction associated with smoking. This may help to prevent the cycle of nicotine addiction.

Chantix is the fourth new Pfizer medicine to receive FDA approval in 2006.


Comments
on Aug 30, 2006
The new Varenicline drug from Pfizer is called Chantix not Chantrix as first released
Neolithic, Tuesday 22 August 2006 - 23:39:57 // comment: 0

The new anti-smoking drug Varenicline will be marketed under the name Chantix not Chantrix as previously stated. The press releases I read all stated Chantrix.

Obviously there must have been an error. The new drug will be marketed as Chantix in the USA and, allegedly it will be marketed under the name Champix in the UK.

I hope it works for everyone who tries it.
on Aug 30, 2006
Thanks for the information Bernie.
on Aug 30, 2006
Addiction to nicotine is a habit that is very difficult for many smokers to quit. When smokers inhale smoke from a cigarette, nicotine reaches the brain within seconds and binds to nicotinic receptors, which activates the reward pathway in brain circuitry. This stimulates the pleasure center in the brain. The initial effects recede quickly and a cycle of craving and withdrawal takes hold.

Chantix is unique because it is specifically designed to partially activate the nicotinic receptor and reduce the severity of the smoker's craving and the withdrawal symptoms from nicotine. Moreover, if a person smokes a cigarette while receiving treatment, Chantix has the potential to diminish the sense of satisfaction associated with smoking. This may help to prevent the cycle of nicotine addiction.

on Oct 24, 2006
Chantix can be effective to help stop smoking. For me, though, some side effects that were not mentioned anywhere were bad enough to make me quit taking the drug. Those were, specifically, aggravation and metalic taste in the mouth. I have been quit using Chantix for about 6 weeks, and my taste has not yet returned to normal. I am wondering if it is a permenent side effect. Anybody else have that problem?